VARUN MONGA: Open Payments
NPI 1639457096 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 36 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $234 |
| ABBVIE INC. | 11 | $227 |
| Teva Pharmaceuticals USA, Inc. | 3 | $78 |
| Almatica Pharma LLC | 2 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: FANAPT, VRAYLAR, AUSTEDO XR, LOREEV XR, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, INGREZZA.
Industry payments across AZ — which companies pay providers there.
